Post-marketing surveillance of new medicines.
作者信息
Smithells R W
出版信息
Br Med J. 1977 Nov 5;2(6096):1218. doi: 10.1136/bmj.2.6096.1218-a.
Abstract
摘要
相似文献
1
Post-marketing surveillance of new medicines.新药上市后监测
Br Med J. 1977 Nov 5;2(6096):1218. doi: 10.1136/bmj.2.6096.1218-a.
2
Post-marketing surveillance of adverse reactions to new medicines.新药不良反应的上市后监测
Br Med J. 1977 Oct 15;2(6093):1001-3. doi: 10.1136/bmj.2.6093.1001.
3
Monitoring of drugs after marketing.药品上市后监测
J R Coll Gen Pract. 1983 Jul;33(252):438-41.
4
Post-marketing drug surveillance: a comparison of methods.药品上市后监测：方法比较
Am J Pharm Sci Support Public Health. 1978 May-Jun;150(3):72-80.
5
Post-marketing surveillance of drugs.药品上市后监测
Br Med J. 1979 Oct 6;2(6194):867. doi: 10.1136/bmj.2.6194.867-c.
6
Medicines update.药物更新。
Vet Rec. 2018 Oct 6;183(13):401-403. doi: 10.1136/vr.k4179.
7
Post-marketing drug surveillance.药品上市后监测
Br J Clin Pharmacol. 1978 Sep;6(3):191-2. doi: 10.1111/j.1365-2125.1978.tb04584.x.
8
A consideration of the guidelines for investigating potential new drugs in humans in the United Kingdom.关于英国人体潜在新药研究指南的思考。
Methods Find Exp Clin Pharmacol. 1979 Apr;1(1):45-50.
9
New strategies for drug monitoring.药物监测的新策略。
Br Med J. 1977 Apr 2;1(6065):861-2.
10
Evaluating drugs: a new approach.评估药物：一种新方法。
Br Med J. 1977 Nov 19;2(6098):1302.
本文引用的文献
1
THE PROBLEM OF TERATOGENICITY.致畸性问题。
Practitioner. 1965 Jan;194:104-10.
2
MECLOZINE AND FOETAL MALFORMATIONS: A PROSPECTIVE STUDY.美克洛嗪与胎儿畸形：一项前瞻性研究。
Br Med J. 1964 Jan 25;1(5377):217-8. doi: 10.1136/bmj.1.5377.217.
Zotero 插件